Directives from President Donald Trump's administration to freeze grant funding from the National Institutes of Health may ...

The health secretary has chipped away at the idea that immunizing children against measles and other diseases is a public ...

The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.

Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary ...

NIH reversed course on its policy barring scientists from attending scientific conferences and meetings without permission, ...

Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why ...

Shares in US biotech Novavax fell more than 20% before the weekend, following remarks from health and human services ...

Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...

By Mariam Sunny and Kamal Choudhury (Reuters) -The U.S. Food and Drug Administration has approved a prefilled syringe version ...

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID ...

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Shares of Novavax Inc. NVAX tumbled 19.56% to $5.43 Thursday, on what proved to be an all-around dismal trading session for ...